93 year old female presented with progressive dyspnea (NYHA Class III). Past medical history is significant for CAD (s/p PCI to LAD in 2016), hypertension, hypercholesterolaemia and aortic stenosis under surveillance. Recent echocardiogram revealed progression to severe aortic stenosis (PG/MG/AVA 92mmHg/51mmHg/0.74cm2) and LVEF of 68%. CT angiogram revealed > 6mm diameter of bilateral common iliac arteries and aortic annulus of 22x18mm (average 20.5m) with annular perimeter of 67mm. STS mortality risk for surgical AVR was 10.1% and the logistic Euroscore mortality risk was 17.1%. Patient underwent surgical evaluation and was found to be at high risk for SAVR. Now presented for percutaneous transfemoral TAVR with Evolut-Pro 26mm valve and Sentinel cerebral protection device.
Mitral ViV TMVR using SAPIEN-3 Valve – May 2019
81 year old female presents with worsening dyspnea on minimal exertion (NYHA class III) over the last few months. Her past medical history is significant for rheumatic heart disease with severe MR and MS s/p bioprosthetic MVR with 29 mm porcine valve (Biocor, St. Jude Medical) along with MAZE procedure in 2007. She also has […]
Valve-in-Valve TAVR with 26mm SAPIEN-3 – March 2019
79 year old man presents with worsening exertional dyspnea (NYHA Class III) for the last 3 months. Patient has required multiple recent admissions to hospital with CHF exacerbation requiring IV diuretics. Past medical history is significant for symptomatic bicuspid aortic valve with dilated ascending aorta s/p Bentall procedure (2011) with 25 mm Carpentier-Edwards pericardial valve […]
Valve-in-Valve TAVR with 29mm Evolut-R CoreValve – January 2019
79 year old man presents with progressive exertional dyspnea (NYHA Class III) for the last 2 months.